Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.7K Buy
793
+8
+1% +$923 0.04% 368
2026
Q1
$93.8K Buy
785
+7
+0.9% +$918 0.05% 339
2025
Q4
$106K Hold
778
0.06% 307
2025
Q3
$115K Hold
778
0.06% 292
2025
Q2
$101K Buy
778
+28
+4% +$3.39K 0.06% 302
2025
Q1
$89.6K Buy
750
+12
+2% +$1.49K 0.06% 310
2024
Q4
$85.6K Hold
738
0.05% 325
2024
Q3
$99.7K Hold
738
0.06% 294
2024
Q2
$100K Buy
+738
New +$100K 0.06% 283

Other funds holding XYL

Cromwell Holdings's XYL Position: Q2 2026 in Review

Cromwell Holdings increased its Xylem (XYL) stake by 1% in Q2 2026, buying an estimated $923 and bringing the position to 793 shares worth $93.7K. The position accounts for 0.04% of the portfolio, ranked #368.

Cromwell Holdings first reported a position in XYL in Q2 2024 and has held it in 9 quarters since. The position peaked at $115K in Q3 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Cromwell Holdings held 793 shares of Xylem worth $93.7K as of Q2 2026.
  • Cromwell Holdings bought 8 Xylem shares in Q2 2026, an estimated $923.
  • Xylem made up 0.04% of Cromwell Holdings's portfolio in Q2 2026, its #368 holding.
  • Cromwell Holdings first reported a position in Xylem in Q2 2024 and has held it in 9 quarters since.
  • Cromwell Holdings's Xylem position peaked at $115K in Q3 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.